Epoprostenol
MeSH ID: M0017816
DEFINITION: A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
Terms:
- Epoprostenol [T033856]
- Epoprostanol [T033861]
- PGI2 [T033862]
- Prostaglandin I(2) [T033858]
- Prostaglandin I2 [T033860]
- Prostacyclin [T033857]
- PGX [T033863]
Descriptors:
Semantic Types:
- Pharmacologic Substance [T121]
- Biologically Active Substance [T123]
- Eicosanoid [T111]
Didn't find what you were looking for?
Portions of this site are from MeSH 2007 which is created, maintained and provided by the U.S. National Library of Medicine.
Neither the United States Government or Slicksurface LLC, nor any of their agencies, contractors, subcontractors or employees make any warranties, express or implied, with respect to data shown on these pages, and, furthermore assume no legal liability for any party's use, or the result of such use.
